Schwartz Jeffrey Lawrence

CIK 00017029579 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001702957

Recent Transactions

50 trades

Award
RAPID MICRO BIOSYSTEMS, INC.$RPID
Class A Common Stock
2024-05-23+14,300→ 14,300 total
Award
RAPID MICRO BIOSYSTEMS, INC.$RPID
Stock Option (Right to Buy)
2024-05-23+28,650→ 28,650 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-24+13,774→ 13,774 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2023-05-24+4,648→ 10,572 total
Award
RAPID MICRO BIOSYSTEMS, INC.$RPID
Stock Option (Right to Buy)
2023-05-04+25,000→ 25,000 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2023-03-16$28.50/sh−1,750,000→ 3,081,307 total
Award
RAPID MICRO BIOSYSTEMS, INC.$RPID
Stock Option (right to buy)
2022-05-23+12,500→ 12,500 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2022-05-19+15,318→ 15,318 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2022-05-19+4,818→ 5,924 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2021-08-10$70.25/sh−1,000,000→ 4,831,307 total
Conversion
RAPID MICRO BIOSYSTEMS, INC.$RPID
Series C1 Preferred Stock
2021-07-19−6,672,819→ 0 total
Purchase
RAPID MICRO BIOSYSTEMS, INC.$RPID
Class A Common Stock
2021-07-19$20.00/sh+100,000→ 8,434,560 total
Conversion
RAPID MICRO BIOSYSTEMS, INC.$RPID
Class A Common Stock
2021-07-19+6,999,998→ 6,999,998 total
Conversion
RAPID MICRO BIOSYSTEMS, INC.$RPID
Class A Common Stock
2021-07-19+1,334,562→ 8,334,560 total
Conversion
RAPID MICRO BIOSYSTEMS, INC.$RPID
Series B1 Preferred Stock
2021-07-19−35,000,001→ 0 total
Award
RAPID MICRO BIOSYSTEMS, INC.$RPID
Stock Option (Right to Buy)
2021-07-14+25,000→ 25,000 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2021-05-20+1,106→ 1,106 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2021-05-20+6,998→ 6,998 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2021-03-09$71.50/sh−1,450,000→ 5,831,307 total
Award
BCLS Acquisition Corp.
Class A ordinary shares
2020-10-26$10.00/sh+487,500→ 487,500 total
Purchase
Aptinyx Inc.
Common Stock
2020-10-26$3.00/sh+3,333,333→ 8,891,758 total
Conversion
Annexon, Inc.$ANNX
Common Stock
2020-07-28+319,243→ 2,841,628 total
Conversion
Annexon, Inc.$ANNX
Common Stock
2020-07-28+2,522,385→ 2,522,385 total
Purchase
Annexon, Inc.$ANNX
Common Stock
2020-07-28$17.00/sh+400,000→ 3,241,628 total
Conversion
Annexon, Inc.$ANNX
Series C Preferred Stock
2020-07-28−22,222,221→ 0 total
Conversion
Annexon, Inc.$ANNX
Series D Preferred Stock
2020-07-28−2,812,543→ 0 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-20+7,464→ 7,464 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2020-02-04+2,825,602→ 2,825,602 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2020-02-04+859,573→ 3,685,175 total
Purchase
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2020-02-04$17.00/sh+294,117→ 3,979,292 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Series B Preferred Stock
2020-02-04−2,825,602→ 0 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Series C Preferred Stock
2020-02-04−859,573→ 0 total
Sale
Dicerna Pharmaceuticals Inc
Common Stock
2019-11-19$22.03/sh−1,750,000→ 5,580,237 total
Conversion
SpringWorks Therapeutics, Inc.
Common Stock
2019-09-17+6,078,103→ 6,078,103 total
Conversion
SpringWorks Therapeutics, Inc.
Common Stock
2019-09-17+1,053,204→ 7,131,307 total
Conversion
SpringWorks Therapeutics, Inc.
Series A Convertible Preferred Stock
2019-09-17−6,078,103→ 0 total
Purchase
SpringWorks Therapeutics, Inc.
Common Stock
2019-09-17$18.00/sh+150,000→ 7,281,307 total
Conversion
SpringWorks Therapeutics, Inc.
Series B Convertible Preferred Stock
2019-09-17−1,053,204→ 0 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2019-09-12+29,983→ 29,983 total
Sale
Dicerna Pharmaceuticals Inc
Common Stock
2019-05-29$12.50/sh−1,600,000→ 7,330,237 total
Award
SpringWorks Therapeutics, Inc.
Series B Convertible Preferred Stock
2019-03-29+6,931,142→ 1,053,204 total
Award
SpringWorks Therapeutics, Inc.
Series A Convertible Preferred Stock
2019-03-29+40,000,000→ 6,078,103 total
Conversion
Replimune Group, Inc.$REPL
Common Stock
2018-07-24+2,338,968→ 2,338,968 total
Purchase
Replimune Group, Inc.$REPL
Common Stock
2018-07-24$15.00/sh+500,000→ 2,838,968 total
Conversion
Replimune Group, Inc.$REPL
Series B Convertible Preferred Stock
2018-07-24−235,146→ 0 total
Sale
MARINUS PHARMACEUTICALS, INC.
Common Stock
2017-12-19$7.11/sh−55,229→ 3,977,453 total
Sale
MARINUS PHARMACEUTICALS, INC.
Common Stock
2017-12-19$7.62/sh−94,771→ 4,032,682 total
Purchase
Dicerna Pharmaceuticals Inc
Common Stock
2017-12-18$7.00/sh+285,000→ 285,000 total
Sale
MARINUS PHARMACEUTICALS, INC.
Common Stock
2017-12-18$7.50/sh−300,000→ 4,127,453 total
Award
Dicerna Pharmaceuticals Inc
Common Stock
2017-12-18+190,849→ 8,930,237 total

Companies

Recent Filings

Address

200 CLARENDON STREET

BOSTON, MA, 02116

View on SEC.gov